Sun Pharma Profit

• 

  Sun Pharma Stock In Focus After Q3 Profit Falls 75%

  Motilal Oswal maintains 'buy' rating on Sun Pharma Stock, while Edelweiss downgrades the scrip rating to 'Hold' from 'Buy'

• 

  Sun Pharma Q3 Profit Slides 75% To Rs 365 Crore, Misses Estimates

  Total revenue from operations fell 16 per cent to 66.53 billion rupees.

• 

  Sensex Extends Record Run, Nifty Hits 10,550

  Sun Pharma, Tech Mahindra, Aurobindo Pharma, Dr Reddy's and Vedanta were among the top gainers on the Nifty 50.

• 

  Sensex Closes Down 106 Points, Nifty Sheds 0.28%, Airtel, Infosys, Tata Motors Biggest Losers

  Sensex closed106 points, 0.31%, lower to 33,619, Nifty shed29 points, or 0.28%, to close at 10,370 points.

• 

  Sensex, Nifty Close Flat, Infosys, RIL, Sun Pharma Top Gainers

  Senex, Nifty on Thursday closed on a flat-to-positive note as investors traded with caution on the back of weak global cues

• 

  Sun Pharma Shares Close 4% Lower As Q2 Profit Falls 60%

  Shares of Sun Pharmaceutical Industries on Wednesday ended 4 per cent lower after the company reported a 59.19 per cent decline in consolidated net profit

• 

  Sun Pharma's Q2 Profit Plunges 59%, Beats Estimates

  Profit came in at Rs 912 crore in the quarter ended September 30, compared with Rs 2,235 crore a year ago, the company said.